N-(3-((1H-pyrazol-3-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-6-morpholinopyridine-3-sulfonamide

InChIKey	`ZRAVHLYAOHIXOD-UHFFFAOYSA-N`
Compound Name	N-(3-((1H-pyrazol-3-yl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-6-morpholinopyridine-3-sulfonamide
Canonical SMILES	`O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(N2CCOCC2)nc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	6.37
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P11712	CYP2C9	Homo sapiens	Human	PF00067	6.7	IC50	ChEMBL;BindingDB
P35462	DRD3	Homo sapiens	Human	PF00001	6.2	Ki	ChEMBL
P50406	HTR6	Homo sapiens	Human	PF00001	6.2	Ki	ChEMBL